Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$79.22 - $105.37 $4,753 - $6,322
60 Added 1.46%
4,156 $423,000
Q1 2023

May 15, 2023

SELL
$30.85 - $93.17 $2,128 - $6,428
-69 Reduced 1.66%
4,096 $372,000
Q4 2022

Feb 10, 2023

BUY
$22.15 - $42.11 $1,528 - $2,905
69 Added 1.68%
4,165 $158,000
Q3 2022

Nov 10, 2022

SELL
$19.41 - $36.49 $116 - $218
-6 Reduced 0.15%
4,096 $102,000
Q2 2022

Aug 12, 2022

BUY
$20.71 - $36.5 $1,242 - $2,190
60 Added 1.48%
4,102 $124,000
Q1 2022

May 12, 2022

SELL
$24.12 - $39.6 $1,519 - $2,494
-63 Reduced 1.53%
4,042 $132,000
Q4 2021

Feb 11, 2022

SELL
$25.61 - $110.96 $153,839 - $666,536
-6,007 Reduced 59.4%
4,105 $108,000
Q3 2021

Nov 05, 2021

SELL
$100.0 - $143.02 $1,400 - $2,002
-14 Reduced 0.14%
10,112 $1.02 Million
Q2 2021

Aug 06, 2021

SELL
$78.27 - $151.29 $5,322 - $10,287
-68 Reduced 0.67%
10,126 $1.43 Million
Q1 2021

May 07, 2021

SELL
$94.25 - $132.81 $942 - $1,328
-10 Reduced 0.1%
10,194 $1.02 Million
Q4 2020

Feb 12, 2021

BUY
$102.03 - $184.62 $3,366 - $6,092
33 Added 0.32%
10,204 $1.26 Million
Q3 2020

Nov 06, 2020

SELL
$93.53 - $163.34 $85,767 - $149,782
-917 Reduced 8.27%
10,171 $990,000
Q2 2020

Aug 07, 2020

SELL
$126.3 - $176.56 $32,585 - $45,552
-258 Reduced 2.27%
11,088 $1.73 Million
Q1 2020

May 08, 2020

BUY
$124.16 - $247.74 $37,248 - $74,322
300 Added 2.72%
11,346 $1.64 Million
Q4 2019

Feb 07, 2020

BUY
$74.57 - $217.92 $73,227 - $213,997
982 Added 9.76%
11,046 $2.26 Million
Q3 2019

Nov 08, 2019

SELL
$71.26 - $95.75 $1,710 - $2,298
-24 Reduced 0.24%
10,064 $808,000
Q1 2019

May 10, 2019

BUY
$51.9 - $101.79 $2,024 - $3,969
39 Added 0.39%
10,088 $0
Q4 2018

Feb 08, 2019

BUY
$48.76 - $76.44 $536 - $840
11 Added 0.11%
10,049 $563,000
Q4 2017

Feb 09, 2018

BUY
$22.39 - $33.27 $850 - $1,264
38 Added 0.38%
10,038 $0
Q3 2017

Nov 13, 2017

BUY
$26.29 - $31.88 $262,900 - $318,800
10,000
10,000 $0

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.